Davis Jerel Net Worth & Insider Trades

Davis Jerel - Director, Chinook Therapeutics, Inc

As of May 31, 2023

What is Davis Jerel's Net Worth?

The current estimated net worth of Chinook Therapeutics, Inc's Director, Davis Jerel, is estimated to be about $153.17M . Davis Jerel owns about 654,709 units of Chinook Therapeutics, Inc common stock. In the last 3 years at Chinook Therapeutics, Inc, Davis Jerel has sold an estimated value of $43.14M worth.

What is Davis Jerel's Past Insider Trading?

Davis Jerel's largest sale order was 1,000,000 units , worth over $16M on January 5, 2022. In total, Davis Jerel has made about 12 transactions over 3 years of their time at Chinook Therapeutics, Inc. Davis Jerel usually trades in April, August and May, with the busiest year in 2022. The most recent transaction was a sale order of 295,808 units , worth over $6.14M on April 19, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jerel Davis

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Davis Jerel's' Mailing Address?

  • Mailing address is One Sansome Street, Suite 3630 San Francisco CA 94104 CA

What are Chinook Therapeutics, Inc's Past Insider Trades?

Chinook Therapeutics, Inc's most recent insider trade came on August 1, 2023 by James Andrew King who sold 1,168 units worth $45.59K . In the last 3 years, insiders at Chinook Therapeutics, Inc have sold an estimated value of $76.88M and bought an estimated value of $28.22M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Eric Dobmeier, President,  James Andrew King, Chief Scientific Officer,  and Tom Frohlich, Chief Operating Officer .

CHINOOK THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...